Yonsei Med J.  1988 Jun;29(2):101-108. 10.3349/ymj.1988.29.2.101.

Early Diagnosis of Hepatocellular Carcinoma Using lmaging Modalities

Affiliations
  • 1Division of Nuclear Medicine Department of Radiation Therapy and Nuclear Medicine, Tomas Jefferson University Hospital, 11th and Walnut Streets Philadelphia, PA 19107, USA.

Abstract

Hepatocellular carcinoma (HCC) is one of the most frequent primary malignancies in the world, and, particularly, it is common in the Far East. In the world, more than one million new cases of HCC are seen each year. The prognosis of patients with HCC is extremely poor with an average survival of about six months following the diagnosis. In order to improve the prognosis of HCC, early diagnosis should be attempted utilizing mass screening methods. Screening of a high-risk population with alpha-fetoprotein (AFP) along with non-invasive medical imaging modalities will lead to early diagnosis of HCC and subsequent improvement of survival. Indeed, recent advances in medical imaging techniques have increased the rate of detection of small HCCs, and such imaging modalities include ultrasonography(US), radionuclide imaging(RNI), computed tomography(CT), magnetic resonance imaging(MRI), and angiography. Each imaging method is reviewed with special emphasis on the early diagnosis of HCC.

Keyword

Hepatocellular carcinoma; alpha-fetoprotein; hepatis B virus; imaging modalities

MeSH Terms

Adult
Aged
Carcinoma, Hepatocellular/*diagnosis
Case Report
Comparative Study
False Negative Reactions
Female
Hepatic Artery/radiography
Human
Liver/pathology/radiography/radionuclide imaging
Liver Neoplasms/*diagnosis
Magnetic Resonance Imaging
Male
Time Factors
Tomography, X-Ray Computed
Ultrasonography
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr